Clinical Trials Logo

Filter by:
NCT ID: NCT06084000 Recruiting - Drug-coated Balloon Clinical Trials

STrategies of Scheduled Drug-coated Balloons (DCB) Versus Conventional DES for the interveNTional Therapy of de Novo Lesions in Large Coronary vESSels (STENTLESS) Trial

STENTLESS
Start date: October 15, 2023
Phase: N/A
Study type: Interventional

This is a multicenter, open-label, randomized controlled study meant to compare the safety and efficacy of scheduled drug-coated balloon (DCB) and conventional drug-eluting stent (DES) strategy in the treatment of de novo lesions of large coronary vessel with diameter larger than 2.75 mm. The trial was designed to provide high-quality evidence for expanding the clinical indications of DCB, and to explore a better way for coronary intervention based on DCB.

NCT ID: NCT06083870 Recruiting - Clinical trials for Non-small Cell Lung Cancer Metastatic

An Early Stage Study to Evaluate Oba01 for Injection in Patients With DR5 Positive LA/mNSCLC

Start date: December 13, 2023
Phase: Phase 1
Study type: Interventional

This study will evaluate the safety, tolerability, pharmacokinetics and efficacy of Oba01 for injection in patients with DR5 positive LA/mNSCLC.

NCT ID: NCT06083831 Recruiting - Critical Illness Clinical Trials

The Effect of Sequential Feeding for Circadian Rhythm and Gut Flora Rhythm in Critically Ill Patients

Start date: October 7, 2023
Phase:
Study type: Observational

Circadian rhythms plays an important role for healthy. And critical illness contributes to the disruption of circadian rhythms. Not only right but also feeding can affect the circadian clock gene expression. In a investigators' previous study, some metabolic indicators (the albumin level, total cholesterol level and total bile acid level) and the increases in lymphocyte counts in the sequential feeding group were different from those in the continuous feeding group. Investigators think sequential feeding may adjust circadian clock gene expression for its effect on metabolism and immunity. Moreover, sequential feeding did alter the abundances of some gut microbes to some degree in the investigators' previous study. Investigators think sequential feeding may adjust gut flora rhythms.

NCT ID: NCT06083779 Recruiting - Endometrial Cancer Clinical Trials

Early Detection of Endometrial Cancer Using Plasma Cell-free DNA Fragmentomics

Start date: August 1, 2023
Phase:
Study type: Observational

The purpose of this study is to enable non-invasive early detection of endometrial cancer in high-risk populations through the establishment of a multimodal machine learning model using plasma cell-free DNA fragmentomics. Plasma cell-free DNA from early stage endometrial cancer patients and healthy individuals will be subjected to whole-genome sequencing. Five different feature types, including Fragment Size Distribution, nucleosome features, SBS Signatures, BreakPoint Motif , and Copy Number Variation will be assessed to generate this model.

NCT ID: NCT06083701 Recruiting - Clinical trials for Peripheral T Cell Lymphoma

Phase I/II Study of Linperlisib Plus Chidamide for R/R Peripheral T-cell Lymphoma: a Prospective, Multi-center Study

Start date: September 25, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

HDAC inhibitor chidamide and PI3K inhibitor linperlisib has shown clinical activity as mono-therapy in PTCL. The combination of duvelisib and romidepsin is highly active for relapsed and refractory PTCLs. The aim of this study is to further explore the efficacy and safety of HDAC inhibitor chidamide combined with PI3K inhibitor linperlisib in the treatment of relapsed and refractory PTCLs.

NCT ID: NCT06083532 Recruiting - Physical Fitness Clinical Trials

Effect of PAP on Lower Limb Explosive Force in Basketball Players in CHINA

Start date: September 15, 2023
Phase: N/A
Study type: Interventional

The phenomenon that high-intensity warm-up activities help improve muscle strength and explosive performance is called post-activation potentiation (PAP), which is a warm-up method that uses high-intensity stimulation to induce the activation of more type II muscle fibers. However, the results of studies exploring the enhancing effect of PAP on lower limb explosive strength are still controversial. In studies with no significant difference, it is believed that there are many factors that affect PAP, such as activation method, activation intensity, recovery time and individual factors, etc., and it is difficult to control during implementation. In addition, traditional warm-up methods such as jogging and stretching have been shown to have limited effectiveness in improving athletes' performance. In the past, there have been many studies on the combination of PAP and lower limb explosive strength, but there are almost no studies on the long-term effects of PAP on the lower limb explosive strength of basketball players. Therefore, this study studies the characteristics of PAP in order to find the best activation scheme for PAP, and then combines the enhancement effect of PAP with the explosive power of the lower limbs to improve the explosive power of the lower limbs of basketball players, and verifies the long-term effect of combining PAP with explosive power training. In order to provide new changes and breakthroughs in the design of physical training for basketball players and improve the sports performance of college male basketball players.

NCT ID: NCT06082934 Recruiting - Clinical trials for Newly-diagnosed Ph+ Acute Lymphoblastic Leukemia

Olverembatinib Plus Venetoclax and Dexamethasone for Treatment-naïve Ph+ Acute Lymphoblastic Leukemia

Start date: November 1, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to explore the efficacy and safety of the OVD chemotherapy-free regimen (Olverembatinib, venetoclax and dexamethasone) in patients with newly-diagnosed Ph+ALL.

NCT ID: NCT06082791 Recruiting - COPD Clinical Trials

A Clinical Validation Study to Evaluate the Diagnostic Accuracy of a Cough-based Auxiliary Diagnosis Algorithm for COPD

Start date: July 1, 2023
Phase:
Study type: Observational

Cough is one of the most common symptoms in COPD patients, and its different characteristics in amplitude, frequency and waveform can be analyzed by intelligent algorithms for the auxiliary diagnosis of COPD. The current study is to conduct external clinical validation of COPD auxiliary diagnosis algorithm and lung function prediction algorithm, and preliminatively verify the performance of the algorithm, with the ultimate goal of developing a portable and rapid COPD auxiliary diagnosis and condition assessment tool that can be used at home.

NCT ID: NCT06082765 Recruiting - Cervical Cancer Clinical Trials

Cervical Cancer Screening With NGS-HPV Technology Based on Menstrual Blood

Start date: September 1, 2021
Phase:
Study type: Observational

Our study is conducted to recruit cervical cancer screening patients to evaluate the application value of using high-throughput sequencing technology to detect HPV in menstrual blood for cervical cancer screening.

NCT ID: NCT06082648 Recruiting - Rectal Neoplasms Clinical Trials

Study of Brain-Gut Function Reconstruction After Intersphincteric Resection for Ultra-Low Rectal Tumors

Start date: June 1, 2023
Phase: N/A
Study type: Interventional

To investigate the effects of intersphincteric resection (ISR) of ultra-low rectal tumor on the brain-rectoanal function of patients, and to precisely localize the cerebral functional regulatory regions for intervention targets of anorectal remodeling. Utilizing transcranial magnetic stimulation(TMS) technology to explore the functional remodeling of the "new" anorectal muscle groups and provide a theoretical basis for more research on the rehabilitation and mechanism of fecal incontinence.